By Robert Preidt
FRIDAY, Feb. fourteen, 2020 (HealthDay Information) — Medication that a lot of adult men with prostate most cancers may well presently be getting — cholesterol-lowering statins — may possibly support prolong their survival if they have a “substantial-chance” sort of the illness, new investigate suggests.
Significant-chance patients consist of adult men with substantial blood amounts of prostate distinct antigen (PSA) and a “Gleason rating” of eight or much more. Gleason scores are a calculation utilised to gauge prognosis in prostate most cancers. Adult males with a substantial Gleason